Trademark: 98151423
Word
ADJUPANRIX
Status
Registered
Status Code
700
Status Date
Tuesday, June 25, 2024
Serial Number
98151423
Registration Number
7429357
Registration Date
Tuesday, June 25, 2024
Mark Type
4
Filing Date
Friday, August 25, 2023
Published for Opposition
Tuesday, April 9, 2024

Trademark Owner History
GlaxoSmithKline Biologicals SA - Original Registrant

Classifications
5 Vaccines

Trademark Events
Aug 29, 2023
New Application Entered
Jan 31, 2024
Assigned To Examiner
Jan 31, 2024
Non-Final Action Written
Sep 20, 2023
New Application Office Supplied Data Entered
Jan 31, 2024
Non-Final Action E-Mailed
Jan 31, 2024
Notification Of Non-Final Action E-Mailed
Mar 1, 2024
Correspondence Received In Law Office
Mar 1, 2024
Teas/Email Correspondence Entered
Mar 1, 2024
Teas Response To Office Action Received
Mar 20, 2024
Notification Of Notice Of Publication E-Mailed
Apr 9, 2024
Published For Opposition
Apr 9, 2024
Official Gazette Publication Confirmation E-Mailed
Jun 25, 2024
Registered-Principal Register
Jun 25, 2024
Notice Of Registration Confirmation Emailed
Mar 4, 2024
Approved For Pub - Principal Register

Trademark Alertz updated from USPTO on 2030-01-24